Skip to content

Clinical trials

Active, not recruiting Leukemia, Myeloid, Acute trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Active, not recruiting Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20161
20171
20181
20192
20201
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Internationales Servier2
Stichting Hemato-Oncologie voor Volwassenen Nederland2
Byondis B.V.1
Celgene1
Daiichi Sankyo1
Novartis Pharmaceuticals1
Seagen, a wholly owned subsidiary of Pfizer1
Syndax Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute10
Leukemia3
Myelodysplastic Syndromes2
Recurrence2
Astrocytoma1
Cholangiocarcinoma1
Glioblastoma1
Glioma1
Hematologic Neoplasms1
Oligodendroglioma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.